Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 11:55AM ET
2.61
Dollar change
+0.03
Percentage change
1.16
%
IndexRUT P/E- EPS (ttm)-3.27 Insider Own42.77% Shs Outstand23.10M Perf Week-1.88%
Market Cap60.37M Forward P/E- EPS next Y-2.69 Insider Trans0.00% Shs Float13.24M Perf Month-10.00%
Income-75.24M PEG- EPS next Q-0.86 Inst Own35.54% Short Float5.22% Perf Quarter-34.91%
Sales0.00M P/S- EPS this Y37.45% Inst Trans- Short Ratio4.04 Perf Half Y4.82%
Book/sh3.46 P/B0.75 EPS next Y10.20% ROA-80.25% Short Interest0.69M Perf Year-
Cash/sh3.37 P/C0.77 EPS next 5Y21.20% ROE-98.71% 52W Range1.62 - 13.20 Perf YTD2.55%
Dividend Est.- P/FCF- EPS past 5Y- ROI-93.23% 52W High-80.23% Beta-
Dividend TTM- Quick Ratio6.72 Sales past 5Y-50.65% Gross Margin85.50% 52W Low60.62% ATR (14)0.30
Dividend Ex-Date- Current Ratio6.72 EPS Y/Y TTM- Oper. Margin0.00% RSI (14)43.03 Volatility8.91% 10.47%
Employees80 Debt/Eq0.03 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price16.50
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q- Payout- Rel Volume1.32 Prev Close2.58
Sales Surprise- EPS Surprise-9.68% Sales Q/Q-100.00% EarningsMay 13 AMC Avg Volume171.08K Price2.61
SMA20-7.40% SMA50-11.08% SMA200-30.03% Trades Volume90,881 Change1.16%
Date Action Analyst Rating Change Price Target Change
Aug-16-23Initiated SVB Securities Market Perform
Aug-15-23Initiated Piper Sandler Overweight $20
Aug-15-23Initiated BofA Securities Buy $18
May-13-24 09:53PM
05:01PM
May-08-24 09:00AM
Apr-16-24 09:00AM
Mar-22-24 07:52AM
05:06PM Loading…
Mar-21-24 05:06PM
Feb-21-24 06:00AM
Feb-20-24 05:00PM
Nov-27-23 06:00AM
Nov-09-23 09:49PM
Nov-03-23 06:00AM
Oct-30-23 06:00AM
Sep-28-23 06:00AM
Sep-01-23 05:57PM
Aug-14-23 08:41PM
06:30PM Loading…
Aug-04-23 06:30PM
Jul-27-23 07:01PM
05:36PM
Jul-21-23 02:15AM
Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It engages in the business of developing and commercializing therapeutics. The company is focused on developing new medicines to treat and cure patients with solid tumors. Turnstone Biologics was founded in 2015 and is headquartered in La Jolla, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jerel DavisDirectorJul 25 '23Buy12.00225,0002,700,0002,726,322Jul 27 04:21 PM
Versant Ventures V, LLC10% OwnerJul 25 '23Buy12.00225,0002,700,0002,726,322Jul 27 04:23 PM
ORBIMED ADVISORS LLCDirectorJul 20 '23Buy12.00416,6664,999,9923,099,265Jul 24 04:38 PM
Gupta RishiDirectorJul 20 '23Buy12.00416,6664,999,9923,099,265Jul 24 04:40 PM